vs
Side-by-side financial comparison of Medirom Healthcare Technologies Inc. (MRM) and Maison Solutions Inc. (MSS). Click either name above to swap in a different company.
Maison Solutions Inc. is the larger business by last-quarter revenue ($27.6M vs $21.1M, roughly 1.3× Medirom Healthcare Technologies Inc.). Maison Solutions Inc. runs the higher net margin — -18.0% vs -21.3%, a 3.3% gap on every dollar of revenue.
Medirom Healthcare Technologies Inc. develops and delivers integrated digital health and remote patient monitoring solutions targeted at chronic disease management, post-operative care, and senior health support. It serves healthcare providers, insurance payers, and institutional care partners across key markets in North America and the Asia-Pacific region, prioritizing accessible, data-driven care to improve patient outcomes.
Maison Solutions Inc.MSSEarnings & Financial Report
Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.
MRM vs MSS — Head-to-Head
Income Statement — Q2 FY2025 vs Q2 FY2026
| Metric | ||
|---|---|---|
| Revenue | $21.1M | $27.6M |
| Net Profit | $-4.5M | $-5.0M |
| Gross Margin | 10.8% | 23.4% |
| Operating Margin | -28.5% | -4.9% |
| Net Margin | -21.3% | -18.0% |
| Revenue YoY | — | -10.9% |
| Net Profit YoY | — | -1840.5% |
| EPS (diluted) | — | $-0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $27.6M | ||
| Q3 25 | — | $27.2M | ||
| Q2 25 | $21.1M | $34.4M | ||
| Q1 25 | — | $32.3M | ||
| Q4 24 | — | $29.4M | ||
| Q3 24 | — | $28.2M | ||
| Q2 24 | — | $16.9M | ||
| Q1 24 | — | $13.6M |
| Q4 25 | — | $-5.0M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | $-4.5M | $-287.4K | ||
| Q1 25 | — | $1.0M | ||
| Q4 24 | — | $-256.0K | ||
| Q3 24 | — | $700.9K | ||
| Q2 24 | — | $-2.8M | ||
| Q1 24 | — | $-549.0K |
| Q4 25 | — | 23.4% | ||
| Q3 25 | — | 24.1% | ||
| Q2 25 | 10.8% | 9.5% | ||
| Q1 25 | — | 21.8% | ||
| Q4 24 | — | 26.9% | ||
| Q3 24 | — | 28.9% | ||
| Q2 24 | — | 13.0% | ||
| Q1 24 | — | 23.4% |
| Q4 25 | — | -4.9% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | -28.5% | -15.9% | ||
| Q1 25 | — | 3.7% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 7.3% | ||
| Q2 24 | — | -14.4% | ||
| Q1 24 | — | -2.3% |
| Q4 25 | — | -18.0% | ||
| Q3 25 | — | -5.7% | ||
| Q2 25 | -21.3% | -0.8% | ||
| Q1 25 | — | 3.1% | ||
| Q4 24 | — | -0.9% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | -16.4% | ||
| Q1 24 | — | -4.0% |
| Q4 25 | — | $-0.23 | ||
| Q3 25 | — | $-0.08 | ||
| Q2 25 | — | $-0.02 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | — | $-0.16 | ||
| Q1 24 | — | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $252.3K | — |
| Total DebtLower is stronger | $8.8M | $2.6M |
| Stockholders' EquityBook value | $1.6M | $11.6M |
| Total Assets | $52.0M | $75.4M |
| Debt / EquityLower = less leverage | 5.55× | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $1.1M | ||
| Q2 25 | $252.3K | $775.4K | ||
| Q1 25 | — | $445.4K | ||
| Q4 24 | — | $355.7K | ||
| Q3 24 | — | $588.9K | ||
| Q2 24 | — | $2.1M | ||
| Q1 24 | — | $9.4M |
| Q4 25 | — | $2.6M | ||
| Q3 25 | — | $2.6M | ||
| Q2 25 | $8.8M | $2.6M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $2.5M | ||
| Q2 24 | — | $2.6M | ||
| Q1 24 | — | $2.6M |
| Q4 25 | — | $11.6M | ||
| Q3 25 | — | $10.1M | ||
| Q2 25 | $1.6M | $11.7M | ||
| Q1 25 | — | $12.0M | ||
| Q4 24 | — | $10.9M | ||
| Q3 24 | — | $11.2M | ||
| Q2 24 | — | $10.5M | ||
| Q1 24 | — | $13.3M |
| Q4 25 | — | $75.4M | ||
| Q3 25 | — | $73.3M | ||
| Q2 25 | $52.0M | $77.4M | ||
| Q1 25 | — | $82.7M | ||
| Q4 24 | — | $82.7M | ||
| Q3 24 | — | $82.1M | ||
| Q2 24 | — | $82.4M | ||
| Q1 24 | — | $44.2M |
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | 5.55× | 0.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.24× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-2.3K | $-1.7M |
| Free Cash FlowOCF − Capex | $-2.4K | — |
| FCF MarginFCF / Revenue | -0.0% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.7M | ||
| Q3 25 | — | $1.1M | ||
| Q2 25 | $-2.3K | $-1.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | — | $3.6M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | — | $-1.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-2.4K | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.66× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.12× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MRM
| Professional services expense | $20.0M | 95% |
| Other | $1.1M | 5% |
MSS
| Perishables | $14.4M | 52% |
| Nonperishables | $13.2M | 48% |